Genetic manipulations are at the cornerstone of nearly every modern biomedical breakthrough.  However, the introduction of engineered sequences into the genomes of model organisms remains a complex, technically demanding and inefficient process.  ArborVita Associates' DRAP technology makes genome editing simpler, faster, and more cost effective.   Our mission is to change the way DNA is modified to create models of human disease pathophysiology, and greatly expand the pace of biomedical research.